These therapies, primarily administered as subcutaneous injectables for ease of at-home use, act by mimicking the native GLP1 hormone, enhancing glucose-dependent insulin secretion, suppressing glucagon release, lowering HbA1c levels, and promoting weight loss - all while carrying a minimal risk of hypoglycemia when used alone
(PubMed) Moses EK, Johnson MP, Tommerdal L, et al
its claim to fame is that it helps suppress hunger by simply wearing a patch for a set amount of time
For a side-by-side comparison of how semaglutide stacks up against the other major GLP-1 option, our semaglutide vs tirzepatide side effects guide compares the safety profiles in detail
The study enrolled 338 participants with obesity across multiple dose groups, tracking outcomes over 48 weeks
Smoking can constrict blood vessels, potentially hindering the absorption of vitamin B12